#morgan-stanley
Latest news and interesting information about morgan-stanley.
Morgan Stanley stock hits all-time high of 208.01 USD
Morgan Stanley stock hits all-time high of 208.01 USD. 62.11% yearly gain, strong earnings, crypto trading on ETrade. Get insights on Bond.az.
Morgan Stanley Raises CMC Price Target
Morgan Stanley raises Commercial Metals price target to $83, citing wide spreads and earnings growth. CMC stock trades at $76.98.
Morgan Stanley Backs AppLovin on Conversion Growth
Morgan Stanley reiterates Overweight on AppLovin with $720 target, highlighting conversion growth potential and strong Q1 results.
Morgan Stanley Initiates Avalyn Pharma with Overweight
Morgan Stanley initiates Avalyn Pharma with Overweight rating and $53 target. The inhaled therapies AP01 and AP02 show promise in pulmonary fibrosis.
Morgan Stanley SWOT: stock navigates trading strength amid fee pressures
Morgan Stanley SWOT analysis: stock navigates trading strength amid fee pressures. Analyst outlook for 2026, buyback program, and key risks.
European steel output falls 2.6%
European steel output fell 2.6% in April. Global production declined 2%. Read more on Bond.az.
Morgan Stanley raises ZTO target to $30.10
Morgan Stanley raises ZTO Express price target to $30.10 from $28.50, maintains Overweight rating, citing profit growth outlook.
Morgan Stanley Cuts Newell Brands Price Target
Morgan Stanley downgraded Newell Brands to Underweight, cutting price target to $3.50 from $4.00. Cost pressures and weak consumer sentiment cited.
Morgan Stanley hikes CAVA price target
Morgan Stanley raises CAVA price target to $86 on strong sales trends. Equalweight rating maintained despite valuation concerns.
Morgan Stanley Reiterates Home Depot Rating on Execution
Morgan Stanley reiterates Overweight rating on Home Depot with $420 target, citing solid execution in a growthless housing market.
Morgan Stanley Initiates Tesco with Overweight Rating
Morgan Stanley starts Tesco with overweight rating and GBP5.60 price target, citing strong momentum.
Morgan Stanley Downgrades Aardvark Stock
Morgan Stanley downgrades Aardvark Therapeutics stock to Underweight, price target $3, after FDA clinical hold on ARD-101 over safety concerns.
Morgan Stanley Downgrades Aegon Stock Rating
Morgan Stanley downgrades Aegon stock to Equalweight, citing limited upside after a 20% rally. Price target remains EUR 7.00.
Morgan Stanley hikes Sunnova stock price target
Morgan Stanley increased Sunnova price target to $494 with a 36x multiple, citing strong execution and growth prospects.
Morgan Stanley Upgrades Assurant Stock Rating
Morgan Stanley upgrades Assurant stock to Overweight, raises price target to $285. Strong earnings and growth outlook highlighted.
Morgan Stanley cuts Amcor price target to $42
Morgan Stanley cuts Amcor price target to $42 from $44, citing lower EPS and EBIT forecasts. Stock near 52-week low.
Morgan Stanley Cuts Global-E Online Price Target
Morgan Stanley cuts Global-E Online price target to $37, maintains Overweight rating. Stock near 52-week low with 15.6% weekly decline. Find more insights.
Morgan Stanley raises Life Time price target
Morgan Stanley lifted Life Time Group price target to $39, citing strong member engagement and positive Q1 2026 results.
...